Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Assembly Biosciences ( (ASMB) ) is now available.
On August 6, 2025, Assembly Biosciences announced interim results from their Phase 1a clinical study of ABI-6250, a candidate for treating hepatitis delta virus (HDV). The company reported positive topline data from a Phase 1b study of ABI-4334 for chronic hepatitis B virus (HBV) and shared updates on their ongoing trials for herpes simplex virus (HSV) candidates ABI-5366 and ABI-1179. Financially, Assembly Biosciences reported a net loss of $10.2 million for the second quarter of 2025, with cash reserves projected to fund operations into mid-2026. The company continues to advance its clinical programs, aiming to deliver impactful datasets for its development candidates by the end of the year.
The most recent analyst rating on (ASMB) stock is a Buy with a $29.00 price target. To see the full list of analyst forecasts on Assembly Biosciences stock, see the ASMB Stock Forecast page.
Spark’s Take on ASMB Stock
According to Spark, TipRanks’ AI Analyst, ASMB is a Neutral.
The overall score reflects significant financial challenges, with the company’s lack of revenue and negative cash flows weighing heavily. However, positive technical momentum and a recent successful clinical trial offer potential upside. Valuation metrics remain weak due to negative earnings, highlighting risk for investors.
To see Spark’s full report on ASMB stock, click here.
More about Assembly Biosciences
Assembly Biosciences is a biotechnology company dedicated to developing innovative small-molecule therapeutics aimed at altering the course of serious viral diseases, including herpesvirus, hepatitis B virus (HBV), and hepatitis delta virus (HDV) infections. The company is led by a team of experts in virologic drug development and is focused on improving patient outcomes worldwide.
Average Trading Volume: 29,071
Technical Sentiment Signal: Hold
Current Market Cap: $144M
See more insights into ASMB stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money